Incannex Healthcare (IXHL) Share-based Compensation (2023 - 2026)
Incannex Healthcare (IXHL) posted Share-based Compensation of -$1.5 million for Q1 2026, up 35.59% sequentially from -$2.3 million in Q4 2025, and down 252.88% YoY from $960201.3 in Q1 2025.
Incannex Healthcare (IXHL) Share-based Compensation (2023 - 2026) Analysis & Trends
Incannex Healthcare has reported Share-based Compensation for 4 years, with the latest figure at -$1.5 million in Q1 2026.
- Quarterly Share-based Compensation fell 252.88% year-over-year to -$1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $177000.0 (down 94.0% YoY) and the FY2025 annual result came in at $2.6 million, down 97.71% from the prior year.
- Share-based Compensation grew to -$1.5 million in Q1 2026 per IXHL's latest filing, from -$2.3 million in the prior quarter.
- Over five years, Share-based Compensation peaked at $3.4 million in Q4 2023 and troughed at -$2.3 million in Q4 2025.
- A 4-year average of $725307.7 and a median of $459000.0 in 2024 frame the typical range for Share-based Compensation.
- The sharpest annual moves came in 2024 and 2025: Share-based Compensation jumped 5764.91% in 2024, then sank 423.91% in 2025.
- Over 4 years, Share-based Compensation stood at $3.4 million in 2023, then tumbled by 112.81% to -$435000.0 in 2024, then tumbled by 423.91% to -$2.3 million in 2025, then jumped by 35.59% to -$1.5 million in 2026.
- According to Business Quant data, Share-based Compensation over the past three periods registered -$1.5 million, -$2.3 million, and $2.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 40.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 26.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 114.12 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 19.00 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 30.40 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 65.00 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 7.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Incannex Healthcare | 44.39 Mn | 44.39 Mn | - | -1.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.47 Mn |
| Mar 31, 2026 | -1.47 Mn |
| Dec 31, 2025 | -2.28 Mn |
| Dec 31, 2025 | -2.28 Mn |
| Sep 30, 2025 | 2.63 Mn |
| Sep 30, 2025 | 2.63 Mn |
| Jun 30, 2025 | 1.30 Mn |
| Jun 30, 2025 | 1.30 Mn |
| Mar 31, 2025 | -416,000.00 |
| Mar 31, 2025 | -416,000.00 |
| Dec 31, 2024 | -435,000.00 |
| Dec 31, 2024 | -435,000.00 |
| Sep 30, 2024 | 459,000.00 |
| Sep 30, 2024 | 459,000.00 |
| Jun 30, 2024 | 3.34 Mn |
| Jun 30, 2024 | 3.34 Mn |
| Mar 31, 2024 | 2.12 Mn |
| Mar 31, 2024 | 2.12 Mn |
| Dec 31, 2023 | 3.40 Mn |
| Dec 31, 2023 | 3.40 Mn |